Index Gains Mask a Narrow Recovery Across Indian Equities
A strong run in selected shares has not yet translated into a broad-based market recovery.
Only 39% of NSE stocks tracked as of November 16 were above their December 2025 closing levels, while fresh highs and lows were recorded by nearly comparable numbers of companies during 2026. The figures point to a market where performance remains concentrated, despite a rally in recent sessions.
Market breadth tells a different story from the rally
The latest market-breadth data show how uneven the recovery has been beneath the headline indices. Of 2,821 NSE stocks traded as of November 16, 1,099, or around 39%, stood above their December 31, 2025 closing levels. The remaining 61% were still below those marks.
That weakness sits alongside notable gains in individual stocks: 682 companies, or 24% of the NSE universe, touched lifetime highs during 2026. Yet 655 stocks, or 23%, also reached fresh lows. In November alone, 132 stocks scaled new peaks while 84 hit new lows. The near balance between these groups suggests that gains in some parts of the market have not lifted the typical listed stock.
Earnings and large-cap leadership shape the divide
The difference in performance is being linked to earnings delivery. Companies with strong second-quarter results have been rewarded, while shares where earnings were subdued have taken longer to recover. That leaves investors distinguishing more sharply between businesses with a clearer growth outlook and those still waiting for improvement.
Recent gains have been concentrated in large-cap banking and financial shares and selected technology stocks. Mid- and small-cap shares, by contrast, have been recovering after steep falls in September and October. This helps explain why a visible rally can coexist with weak market breadth: strength in index heavyweights can lift the benchmark without a comparable advance across the wider market.
BSE figures confirm the uneven participation
The pattern is not confined to the NSE. On the BSE, 1,560 of 4,259 tracked stocks, or 36%, were above their December 2025 closing levels. While 773 stocks touched fresh highs during 2026, 528 reached new lows. November saw 148 shares make new peaks and 64 hit fresh lows.
The comparison reinforces the point that index performance alone may not capture the experience of investors holding a broader mix of shares. Even within market segments that are near their highs, individual stocks can lag. Investors therefore have reason to look beyond benchmark levels when assessing whether a recovery is gaining wider participation.
What could signal a broader advance
The recovery since October 30 has been described as foreign-led, with more than ₹55,000 crore flowing into banks and index heavyweights alone. Analysts have pointed to high interest rates, earnings concentrated among larger companies, elevated crude prices and substantial primary issuances as factors weighing on liquidity and participation. These are pressures to monitor, rather than proof that the market’s direction is settled.
One analyst’s preferred measure is whether the number of advancing stocks rises from roughly 1,100 towards 1,500. Such an improvement would suggest that buying is spreading beyond a narrow group of market leaders. Until breadth strengthens, investors may continue to see sharply different outcomes across stocks, even during sessions when the broader indices appear firm.
Key Highlights
- Around 39% of the 2,821 NSE stocks tracked were above their December 2025 closing levels.
- During 2026, 682 NSE stocks reached lifetime highs and 655 touched fresh lows.
- NSE market breadth was slightly stronger than the BSE reading, but both showed limited participation.
- Recent leadership has centred on large-cap banks, financial companies and select technology stocks.
- A sustained rise in advancing stocks would offer a clearer sign of a broadening recovery.
Investor Note: Treat index strength and stock-level breadth as separate signals. Before acting on a market rally, assess whether the companies under consideration are showing earnings support and whether participation is widening; the current data point to continued dispersion rather than a uniform recovery.
Stay Ahead of the Market 📈
Subscribe to our weekly newsletter
Get your weekly market summary from FinBrooks Insights and smart financial lessons from FinBrooks Academy delivered straight to your inbox every weekend!